Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.
Naing A, Mahipal A, Javle M, Wang J, Bauer TM, Bajor DL, Elias AD, Shields A, Davis E, Chawla S, Safran H, Powderly JD, D'Amato G, Meyer CF, Tang X, Yao S, Keegan P.
Naing A, et al. Among authors: wang j.
J Immunother Precis Oncol. 2025 Jan 15;8(1):71-81. doi: 10.36401/JIPO-24-8. eCollection 2025 Feb.
J Immunother Precis Oncol. 2025.
PMID: 39816916
Free PMC article.